Letter to the Editor Regarding Aranguri et al.
To the Editor:--The article "Patterns of Communication through Interpreters: A Detailed Sociolinguistic Analysis ''I offers many valuable insights into the problems that language barriers may pose for the medical interview. The use of discourse analysis grounded in sociolinguistic theory provides an exciting view of what happens in medical encounters involving language barriers. For example, Elderkin-Thompson et al. 2 used qualitative discourse analysis to describe problems arising when untrained bilingual, bicultural nurses were used as interpreters. More recently, Garces has used institutional discourse analysis to study differences between medical encounters involving language concordant providers and encounters using trained [professional] and untrained [ad hoc] interpreters, a Unfortunately, this study repeats a common methodologic error by not differentiating between untrained and trained "interpreters" http://www.ncihc, org/NCIHC_PDF/TheTerminologyofHealthCarelnterpreting.pdf. 4 Consequently, the article appears to be about the pitfalls of medical interpretation when it is really about problems that arise when using untrained interpreters. The errors that the untrained interpreters in this study make are the very ones that training aims to prevent: summarizing, altenng meaning, and interfering with the relationship between the patient and physician. Studies involving trained, qualified interpreters have demonstrated that they outperform untrained interpreters and offer a means to reduce language-based disparities in health care in as varied realms as satisfaction, access, quality, time, and cost? -l° Unfortunately, the article, as currently titled, may serve to perpetuate the belief that there is no difference between trained and untrained interpreters. It would have been more appropriate for this article to have been titled: "Patterns of Miscommunication through Untrained Interpreters," in order to more accurately convey what the research is about.
We encourage the authors to continue this important work, but to study the performance of professional interpreters. Many hypotheses come to mind: Might the "coldness" in the interview abate as professionals facilitate "small talk?" Do trained medical interpreters adequately transmit the "meaning" of messages while conserving valuable time in the interview?. As the field of medical interpretation matures, our research community should partner prospectively with these fellow professionals to design studies that clearly study the performance of trained, professional interpreters.
Finally, all research involving medical interpreting should explicitly address the qualifications of the interpreters as well as how LEP patients are identified. Only then can we be assured that we are measuring the true impact of medical interpreters.
Respectfully 
Letter to the Editor Regarding Kolodner et al.
To the Editor:--Kolodner et al.'s multicenter study 1 concludes that preoperative ~-blocker was significantly underutilized when compared with the current guideline recommendations. Despite the authors' acknowledgment that part of this underutilization is because of ongoing clinical questions regarding the appropriate selection of candidates for this therapy, the study design and the population described in this publication assumes that there is adequate evidence-based data supporting perioperative ~-blocker use in patients with coronary artery disease (CAD) risk factors. We make objection to this conclusion.
The authors cite the results of 2 randomized clinical trials carried out by Mangano and Poldermans and their colleagues. Mangano's study of 200 patients has been criticized since its publication a decade ago. Many concerns have been appropriately raised with regard to the analysis of only postdischarge data and the exclusion of 6 inpatient deaths (while patients were receiving the study drug postrandomization). Inclusion of these deaths in the analysis contradicts the conclusion of the study. Poldermans' study of 112 patients was un-blinded and limited to a very small group of highly selected patients undergoing vascular surgery. Data from 3 recent large null studies totaling 1,521 subjects (MaVS, POBBLE and DIPOM) failed to show any benefit. Additionally, Devereaux's review of 22 trials (that randomized a total of 2,437 patients) concluded that the evidence is too unreliable to allow definitive conclusions to be drawn. This meta-analysis clearly demonstrates that preoperative ~-blockade is not without risk. Devereaux concluded that the individual safety outcomes in patients treated with perioperative ~-blockers showed a relative risk for bradycardia needing treatment of 2.27 (95% confidence interval [CI] 1.53 to 3.36) and nominally statistically significant relative risk for hypotension requiring treatment of 1.27 (95% CI 1.04 to 1.56).
In addition, the authors cite that many organizations have identified perioperative I3-blockade as a quality measure. 2 We acknowledge that pay for performance is inevitable. Yet, the public and medical community's perception is that quality measures are based on recommendations derived from data supported by body of evidence-based literature. However, it can be readily appreciated that many guidelines, including I.
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